AvantGen
San Diego, California, United States
About AvantGen
AvantGen is a San Diego-based biotechnology company founded in 2006 with Therapeutic and Research & Diagnostic divisions. Its Therapeutic Division is dedicated to novel human antibody discovery, antibody humanization, antibody affinity maturation and optimization for therapeutic development. AvantGen has a proprietary and robust yeast display system, large natural human antibody database, fully human antibody (Germliner™) libraries and screening technologies and collaborates with pharmaceutical and biotechnology companies to facilitate and speed their path to antibody-based therapeutic development through services, partnerships, and licensing.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Last round: Grant (May 2021)
- Website: avantgen.com
- Phone: 858-381-5214
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/avantgen-2477209 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.